期刊文献+

血栓抽吸结合血栓部位注射替罗非班在急诊PCI中的应用 被引量:15

Thrombus aspiration catheters combined with tirofiban injection through the aspiration catheter during emergency percutaneous coronary intervention
原文传递
导出
摘要 目的:前瞻性随机比较急性ST段抬高型心肌梗死(STEMI)患者实施直接经皮冠脉介入(PCI)及血栓抽吸术中,经抽吸导管注射替罗非班与经静脉注射替罗非班的临床疗效。方法:入选因STEMI行直接PCI术并使用血栓抽吸患者113例,随机分为为超选组61例和静脉组52例,观察PCI后冠脉TIMI血流,心肌呈色分级,ST段回落程度,CK-MB峰值,术后血NT Pro-BNP值、术后LVEF及主要心血管事件(MACE)发生率。结果:①术后超选组较静脉组TIMI 3级血流获得率、心肌MBG 3级获得率及术后2hST段回落率高(P=0.019,0.027,0.037),超选组CK-MB峰值、术后7d及术后30dNT pro-BNP值较静脉组低(P=0.012,0.031,0.009);②术后30d超选组LVEF高于静脉组(P=0.045),LVEDd、LVESd小于静脉组(P=0.048,0.037);③超选组较静脉组总MACE发生有降低趋势,但差别无统计学意义(P=0.153)。结论:STEMI患者在行直接PCI及血栓抽吸术时经抽吸导管注射替罗非班可显著改善心肌再灌注及近期预后。 Objective:To compare the clinical efficacy of tirofiban injection through the thrombus aspiration catheter versus through the transvenous approach during primary percumneous coronary intervention(PPCI)in patients with acute ST-segment elevation myocardial(STEMI).Method:113STEMI patients who received primary PCI and thrombus aspiration were selected.61of them were allocated to the special-selected group that received tirofiban injection through the thrombus aspiration catheter and 52of them were allocated to the transvenous group that received tirofiban injection through the intravenous injection.The TIMI flow grade of coronary,myocardial blush grade,the ST-segment resolution,the peak value of CK-MB,the value of NT pro-BNP,the left ventricle ejection fraction(LVEF)after PCI and major adverse cardiac events(MACE)rates were recorded.Result:①The thrombolysis in myocardial infarction(TIMI)grade 3flow of coronary,myocardial blush grade of 3(MBG-3)and the ST-segment resolution in special-selected group were superior than those in transvenous group(P=0.019, 0.027,0.037).The peak value of CK-MB and the value of NT pro-BNP 7days and 30days after PCI in special-selected group were lower than those in transvenous group(P=0.012,0.031,0.009);②The LVEF 30days after PCI in special-selected group were higher than those in transvenous group(P=0.045),while the LVEDd and LVESd were lower than those in transvenous group(P=0.048,0.037);③MACE rates in special-selected group were lower than that in transvenous group,but the difference was not statistically significant(P=0.153).Conclusion:Tirofiban injection through the thrombus aspiration catheter is effective during primary PCI in STEMI,which will improve re-perfusion and short-term prognosis.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第5期384-387,共4页 Journal of Clinical Cardiology
基金 广东省科技计划项目资助(No:2012B061700012)
关键词 急性心肌梗死 经皮冠状动脉介入治疗 血栓抽吸导管 替罗非班 acute myocardial infarction percutaneous coronary intervention thrombus aspiration catheter tiro-fiban
  • 相关文献

参考文献6

  • 1中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012,40(4):271-277. 被引量:426
  • 2YUNOKI K, NARUKO Thrombus Aspiration T, SUGIOKA K, et al. Therapy and Coronary Thrombus Components in Patients with Acute ST-El- evation Myocardial Infarction [J ]. J Atheroscler Thromb, 2013 Apr 30, PMID:23629150.
  • 3冼伟进,余泽洪,陈小林,何北海,汤立军,邹袆,区转焕,梁美合.血栓抽吸导管联合经抽吸导管冠状动脉内注射替罗非班在急性心肌梗死急诊介入中应用的临床研究[J].中国综合临床,2012,28(7):694-697. 被引量:18
  • 4SOBIERAJ D M, WHITE C M, KLUGER J, et al.Systematic review., comparative effectiveness of ad- junctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coro- nary intervention of native vessels[J]. BMC Cardio- vasc Disord, 2011, 11:74-77.
  • 5ROULE V, DAHDOUH Z, WAIN-HOBSON J, et aL Thrombus-aspiration through 5 Fr guiding catheter with transradial approach in acute coronary syn- dromes: feasibility of a mini-invasive strategy[J]. J Interv Cardiol, 2012, 25:323-329.
  • 6ORTOLANI P, MARZOCCHI A, MARROZZINI C, et al. Long-term effectiveness of early administration of glycoprotein lIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: re- sults of a registry study in an ST-elevation myocardial infarction network[J]. Eur Heart J, 2009,30 : 33 - 43.

二级参考文献15

  • 1Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
  • 2Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
  • 3Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 4Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
  • 5Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
  • 6Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
  • 7Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
  • 8Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.
  • 9Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751.
  • 10Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 2011,123:2736-2747.

共引文献442

同被引文献162

引证文献15

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部